ImmunoTHerapy Adjacent to Cervical CAncer (ITHACA) Study

NCT06095674 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer

Interventions

DRUG: Anti-PD-1 antibody balstilimab

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Collaborators

[object Object]
[object Object]